Vir Biotechnology, Inc. (VIR) — 8-K Filings

All 8-K filings from Vir Biotechnology, Inc.. Browse 18 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (18)

  • 8-K Filing — Dec 16, 2025
  • Vir Biotechnology Files 8-K — Jul 24, 2025 Risk: low
    Vir Biotechnology, Inc. filed an 8-K on July 24, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific de
  • Vir Biotechnology Files 8-K on Security Holder Votes — May 29, 2025 Risk: low
    Vir Biotechnology, Inc. filed an 8-K on May 29, 2025, to report on matters submitted to a vote of its security holders. The filing does not disclose specific de
  • Vir Biotechnology Files 8-K — May 9, 2025 Risk: low
    Vir Biotechnology, Inc. filed an 8-K on May 9, 2025, reporting other events and financial statements. The filing details the company's principal executive offic
  • Vir Biotechnology Files 8-K on Financials — May 7, 2025 Risk: low
    Vir Biotechnology, Inc. filed an 8-K on May 7, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibit
  • Vir Biotechnology Files 8-K on Financials — Feb 26, 2025 Risk: low
    Vir Biotechnology, Inc. filed an 8-K on February 26, 2025, reporting on its results of operations and financial condition. The filing includes financial stateme
  • Vir Biotechnology Announces Board and Executive Changes — Jan 30, 2025 Risk: medium
    Vir Biotechnology, Inc. announced on January 24, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company repo
  • Vir Biotechnology Files 8-K — Jan 8, 2025 Risk: low
    Vir Biotechnology, Inc. filed an 8-K on January 8, 2025, reporting on events including a Regulation FD Disclosure, other events, and financial statements/exhibi
  • Vir Biotechnology Files 8-K on Financials — Oct 31, 2024 Risk: low
    Vir Biotechnology, Inc. filed an 8-K on October 31, 2024, reporting on its results of operations and financial condition, as well as financial statements and ex
  • Vir Biotechnology Director Departs Board — Sep 10, 2024 Risk: medium
    Vir Biotechnology, Inc. announced on September 6, 2024, the departure of Dr. George Yancopoulos from its Board of Directors. Dr. Yancopoulos, who also served as
  • Vir Biotechnology Enters Material Definitive Agreement — Aug 1, 2024 Risk: medium
    On July 31, 2024, Vir Biotechnology, Inc. entered into a material definitive agreement. The filing does not disclose the specific details of this agreement, suc
  • Vir Biotechnology Files 8-K — Jun 26, 2024 Risk: low
    Vir Biotechnology, Inc. filed an 8-K on June 26, 2024, to report other events and financial statements/exhibits. The filing does not detail specific transaction
  • Vir Biotechnology Files 8-K — Jun 5, 2024 Risk: low
    Vir Biotechnology, Inc. filed an 8-K on June 5, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain sp
  • Vir Biotechnology Files 8-K on Security Holder Vote — May 29, 2024 Risk: low
    Vir Biotechnology, Inc. filed an 8-K on May 29, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific det
  • Vir Biotechnology Files 8-K on Operations and Financials — May 2, 2024 Risk: low
    Vir Biotechnology, Inc. filed an 8-K on May 2, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibit
  • Vir Biotechnology Files 8-K on Executive and Board Changes — Apr 18, 2024 Risk: medium
    Vir Biotechnology, Inc. filed an 8-K on April 18, 2024, reporting on events as of April 15, 2024. The filing covers the departure of directors or certain office
  • Vir Biotechnology Files 8-K on Material Agreement & Financials — Feb 22, 2024 Risk: medium
    Vir Biotechnology, Inc. filed an 8-K on February 22, 2024, reporting an event that occurred on February 21, 2024. The filing indicates an entry into a material
  • Vir Biotechnology Files 8-K on Officer Changes & Compensation — Feb 20, 2024 Risk: medium
    Vir Biotechnology, Inc. filed an 8-K on February 20, 2024, reporting an event that occurred on February 19, 2024. The filing pertains to Item 5.02, specifically

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.